R. Rask‐Nielsen
- Co-authors
- H. E. ChristensenPeter EbbesenH GormsenJ.F. HeremansJoseph G. TullyJ. ClausenJens ClausenO. H. Iversen
- Topics
- Chronic Lymphocytic Leukemia Research (7 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers)Virus-based gene therapy research (3 papers)
- Cited by
- ImmunologyMicrobiologyHematology
- Partner nations
- DenmarkUnited StatesBelgium
In The Last Decade
R. Rask‐Nielsen
30 papers receiving 228 citations
Peers
Comparison fields: 5 of 65
- Molecular Biology 106
- Immunology 73
- Epidemiology 39
- Oncology 38
- Genetics 38
Countries citing papers authored by R. Rask‐Nielsen
This map shows the geographic impact of R. Rask‐Nielsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Rask‐Nielsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Rask‐Nielsen more than expected).
Fields of papers citing papers by R. Rask‐Nielsen
This network shows the impact of papers produced by R. Rask‐Nielsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Rask‐Nielsen. The network helps show where R. Rask‐Nielsen may publish in the future.
Co-authorship network of co-authors of R. Rask‐Nielsen
This figure shows the co-authorship network connecting the top 25 collaborators of R. Rask‐Nielsen. A scholar is included among the top collaborators of R. Rask‐Nielsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Rask‐Nielsen. R. Rask‐Nielsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 5 | |
| 3 | Plasma cell leukemia in BALB-c mice inoculated with subcellular material. I. Incidence and morphology. | 8 |
| 4 | 20 | |
| 5 | 9 | |
| 6 | 9 | |
| 7 | 16 | |
| 8 | 4 | |
| 9 | 10 | |
| 10 | 30 | |
| 11 | Beta-2A (beta-3-II, gamma-1A) mouse leugenerative lesions in muscles. | 2 |
| 12 | 16 | |
| 13 | 9 | |
| 14 | [The ultracentrifugation of serum proteins in 3 sorts of transplantable mouse leukemia]. | 1 |
| 15 | 16 | |
| 16 | 4 | |
| 17 | 3 | |
| 18 | 4 | |
| 19 | On spontaneous and induced plasma cell neoplasia in a strain of mice. | 1 |
| 20 | 21 |
About R. Rask‐Nielsen
R. Rask‐Nielsen is a scholar working on Genetics, Microbiology and Immunology, having authored 32 papers that have together received 306 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Immunology (73 citations), Microbiology (17 citations) and Hematology (30 citations). R. Rask‐Nielsen has collaborated with scholars based in Denmark, United States and Belgium. Frequent co-authors include H. E. Christensen, Peter Ebbesen, H Gormsen, J.F. Heremans, Joseph G. Tully, J. Clausen, Jens Clausen, O. H. Iversen, K. Robert McIntire and Erik Andreasen. Their work appears in journals such as Nature, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.